BDX vs JUNS · P/E 34, rev $21.84B vs rev $21.8K
Becton Dickinson and Company (BDX) versus Jupiter Neurosciences, Inc. Common Stock (JUNS) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Jupiter Neurosciences, Inc. Common Stock (JUNS) is a biotechnology company listed on NASDAQ.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported JUNS revenue for 2025-12-31 was $21.8K. Net income was -$8.6M. JUNS currently screens at market cap $10.0M.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. JUNS currently screens at market cap $10.0M.
Not investment advice. Open the BDX and JUNS stock pages for the full models.
Not investment advice.